CO5160317A1 - Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene - Google Patents

Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene

Info

Publication number
CO5160317A1
CO5160317A1 CO00041883A CO00041883A CO5160317A1 CO 5160317 A1 CO5160317 A1 CO 5160317A1 CO 00041883 A CO00041883 A CO 00041883A CO 00041883 A CO00041883 A CO 00041883A CO 5160317 A1 CO5160317 A1 CO 5160317A1
Authority
CO
Colombia
Prior art keywords
microgranules
morphine sulfate
procedure
preparation
composition containing
Prior art date
Application number
CO00041883A
Other languages
English (en)
Spanish (es)
Inventor
Dominique Marechal
Suplie Pascal
Oury Pascal
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5160317(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of CO5160317A1 publication Critical patent/CO5160317A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CO00041883A 1999-06-09 2000-06-06 Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene CO5160317A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907259A FR2794646B1 (fr) 1999-06-09 1999-06-09 Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Publications (1)

Publication Number Publication Date
CO5160317A1 true CO5160317A1 (es) 2002-05-30

Family

ID=9546553

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00041883A CO5160317A1 (es) 1999-06-09 2000-06-06 Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene

Country Status (24)

Country Link
US (2) US7063864B1 (https=)
EP (3) EP1627631B1 (https=)
JP (1) JP4296562B2 (https=)
KR (1) KR100676123B1 (https=)
CN (1) CN1267089C (https=)
AR (2) AR024313A1 (https=)
AT (2) ATE354356T1 (https=)
AU (1) AU769160C (https=)
BR (1) BRPI0011404B8 (https=)
CA (1) CA2376339C (https=)
CO (1) CO5160317A1 (https=)
CY (1) CY1107612T1 (https=)
DE (1) DE60033519T2 (https=)
DK (2) DK1189602T3 (https=)
ES (2) ES2280226T3 (https=)
FR (1) FR2794646B1 (https=)
HK (1) HK1045107B (https=)
MX (1) MXPA01012751A (https=)
NZ (1) NZ516077A (https=)
PT (2) PT1627631E (https=)
SI (1) SI1189602T1 (https=)
TW (1) TWI224510B (https=)
WO (1) WO2000074659A1 (https=)
ZA (1) ZA200110087B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
US20190038769A1 (en) * 2010-12-01 2019-02-07 Gowey Research Group, Pllc Micro-rna profiling, compositions, and methods of treating diseases
JP2012250926A (ja) * 2011-06-01 2012-12-20 Nitto Denko Corp 粒子製剤
AU2013285988A1 (en) 2012-07-06 2015-02-12 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
AU2018390826B2 (en) 2017-12-20 2024-09-12 Purdue Pharma L.P. Abuse deterrent morphine sulfate dosage forms

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
GB9119958D0 (en) 1991-09-18 1991-10-30 Unilever Plc Detergent compositions
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
SE9301057L (sv) 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5460826A (en) 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Also Published As

Publication number Publication date
FR2794646A1 (fr) 2000-12-15
JP4296562B2 (ja) 2009-07-15
DE60033519D1 (de) 2007-04-05
WO2000074659A1 (fr) 2000-12-14
EP1189602B1 (fr) 2007-02-21
PT1189602E (pt) 2007-05-31
ES2379688T3 (es) 2012-04-30
BR0011404B1 (pt) 2013-03-05
CA2376339C (fr) 2011-05-17
CN1390121A (zh) 2003-01-08
PT1627631E (pt) 2012-05-21
DK1189602T3 (da) 2007-07-02
CY1107612T1 (el) 2013-03-13
BR0011404A (pt) 2002-03-05
FR2794646B1 (fr) 2001-09-21
ATE354356T1 (de) 2007-03-15
SI1189602T1 (sl) 2007-06-30
AU769160C (en) 2006-02-23
CN1267089C (zh) 2006-08-02
AR068015A2 (es) 2009-10-28
EP1818051A1 (fr) 2007-08-15
DK1627631T3 (da) 2012-04-30
HK1045107B (zh) 2007-05-11
BRPI0011404B8 (pt) 2021-05-25
HK1045107A1 (en) 2002-11-15
AR024313A1 (es) 2002-09-25
AU769160B2 (en) 2004-01-15
DE60033519T2 (de) 2007-10-31
EP1627631A2 (fr) 2006-02-22
KR20020031338A (ko) 2002-05-01
JP2003520770A (ja) 2003-07-08
KR100676123B1 (ko) 2007-01-31
US20070003620A1 (en) 2007-01-04
TWI224510B (en) 2004-12-01
AU5539400A (en) 2000-12-28
ES2280226T3 (es) 2007-09-16
NZ516077A (en) 2004-06-25
EP1627631A3 (fr) 2006-03-15
EP1627631B1 (fr) 2012-02-08
CA2376339A1 (fr) 2000-12-14
EP1189602A1 (fr) 2002-03-27
ATE544448T1 (de) 2012-02-15
US7063864B1 (en) 2006-06-20
MXPA01012751A (es) 2002-07-02
ZA200110087B (en) 2003-03-03

Similar Documents

Publication Publication Date Title
AR068015A2 (es) Microgranulos de sulfato de morfina procedimiento para su preparacion y composicion que los contiene
PT87081A (pt) Controlled release formulations
DE69232687D1 (de) Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
JP2003512395A5 (https=)
AR241680A1 (es) Una composicion para la alimentacion de rumiantes.
ATE419840T1 (de) Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
PE20110544A1 (es) Formulacion farmaceutica de liberacion controlada que comprende isomero r de lansoprazol
MX9304053A (es) Composicion adhesiva destinada principalmente como un adhesivo para el tejido.
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
TR199902484T2 (xx) Biyolojik y�nden aktif maddeler ihtiva eden yap���c� mikrokaps�ller
DE69506890D1 (de) Dynamische kontrolle vom schaufelspitzenspiel
YU48607B (sh) Transdermalni terapeutski sistem (tts) za odavanje galantamina
FR2752732B1 (fr) Forme galenique a liberation prolongee de milnacipran
ATE407674T1 (de) Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
FI861923A7 (fi) Suulakepuristettavien mikropartikkeleidenvalmistuksessa käytettäviä koostumuksia, jotka aiheuttavat biologisestaktiivisen aineen pitkittyneen vapautumisen, ja näin saadut mikropartikkelit.
BR8303287A (pt) Conjunto de pino de ancoragem de suporte de freio
DE69535109D1 (de) Trennmittelzusammensetzung
IT1257793B (it) Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
DE3887839D1 (de) Trennmittelzusammensetzung.
AR004410A1 (es) Microgranulos de liberacion prolongada que contienen diltiazem como principio activo
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
NO992098L (no) Preparat med regulert avgivelse av aktiv forbindelse
ATE341312T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter freisetzung